title: [Effect of combined therapy with Kangyanling and Omeprazole on digestive dysfunction in burned patients].
abstract: OBJECTIVE
  To observe the curative effects of combined therapy with Kangyanling (KYL, a Chinese herbal preparation) and Omeprazole on post-burn digestive dysfunction.
  
  
  METHODS
  Patients with post-burn digestive dysfunction were assigned to two groups, the 32 in the treated group, including 18 with acute stress gastrointestinal mucosal hemorrhagic lesion and 14 with toxic enteroparalysis, were treated by KYL plus Omeprazole, and the 20 patients in the control group, 11 with acute stress gastrointestinal mucosal hemorrhagic lesion and 9 with toxic enteroparalysis were treated with Omeprazole alone. The pH value in gastric mucosa was determined before and 12 h after treatment, the hemostasis effects in 48 h, and the anti-paralysis effects in 72 h were observed as well.
  
  
  RESULTS
  The pH value in gastric mucosa of both groups before therapy were all lower than the normal range, it raised after treatment in the treated group (P < 0.05), approaching to the normal range, but with no significant change in the control group. The total hemostatic rate and the anti-paralysis rate was 77.8% and 85.7% respectively in the treated group, and 45.5% and 0% in the control group, all shown statistical significance between groups (P < 0.05).
  
  
  CONCLUSIONS
  Combined therapy with Kangyanling and Omeprazole has obvious curative effects on post-burn gastric dysfunction.
authors.affiliation: The Third Surgical Department, The 169th Hospital of PLA, Hunan.
authors.forename: Zhi-Ren
authors.initials: ZR
authors.lastname: Song
authors.forename: Zhi-Yun
authors.initials: ZY
authors.lastname: Liu
authors.forename: Lu
authors.initials: L
authors.lastname: Cheng
mesh_terms: D000293:Adolescent; D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications*; D002648:Child; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D008517:Phytotherapy; D013272:Stomach Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000897:Anti-Ulcer Agents; D004365:Drugs, Chinese Herbal; C534021:kangyanling; D009853:Omeprazole